EmBi12 - FACEIT level 10, 2,607 ELO

Poland
On FACEIT since 2015 202 matches tracked 43 matches in 30 days
ELO ▲ 62
2,607
30-day peak: 2,612
Rank EU
#36,350
Poland #1,882 in Poland
Last updated:

EmBi12 at a glance

Level 10 2,607 ELO best map Dust 2 (64%)
2,500-2,749 ELO

Last 20 matches compared with 2,991 players in this group: K/R and ADR below average, win rate above average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 12%
0.90
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.37 ConsistencyShare of matches with a rating of 0.90 or higher. 40%
K/R
0.63
better than 9% of players
2,500-2,749 ELO avg: 0.74
Last 12 months
ADR
71.9
better than 11% of players
2,500-2,749 ELO avg: 81.1
Last 12 months
Win rate
60%
better than 75% of players
2,500-2,749 ELO avg: 50%
Last 12 months

Facts

93 ELO Next goal ELO to 2,700
4 Comebacks last 90 days
4 W · 4 L Overtime in overtime
Mirage Favorite map 64 of 202 matches
Dust 2 64% Map pool tip weakest: Cache 38%
19:00-23:00 Playing times most active
On Tuesdays Best time 64% win rate vs. 53%
FormMapsTiming

93 ELO away from 2,700 ELO. 4 wins after trailing at halftime (last 90 days). 8 matches in overtime, 4 of them won (last 90 days). Most played: Mirage (64 of 202 matches). Strongest map: Dust 2 (64% win rate, 25 matches). Weakest: Cache (38%, 13 matches). Plays most between 19:00 and 23:00 (based on 202 matches). Best results on Tuesdays: 64% win rate vs. 53% overall (28 matches).

About EmBi12

EmBi12 plays CS2 on FACEIT level 10 with 2,607 ELO. The stats cover 202 matches. The strongest map is Dust 2 with a 64% win rate in 25 matches. Most played: Mirage with 64 matches and a 58% win rate. Biggest strength: Headshot rate at 60%, better than 94% of level 10 · 2,500-2,749 ELO players. EmBi12 won 4 matches after trailing at halftime (last 90 days). Last 20 matches: 12 wins, 8 losses, +86 ELO. EmBi12 does best on Tuesdays: 64% win rate in 28 matches.